u/ruben_cabrera

Which country? Half the answers in this thread only apply in Denmark.

This is correct. The naming is genuinely confusing.

This is correct. 3mL versus 12mL is the common mistake.

Every time this gets posted it hits the front page and every time someone has to re-explain it.

Adding to this: regulatory is doing more work than the comment implies.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

the concentration on the vial in marker is the most important step

This is a good question, genuinely.

The beginner question took me three weeks to understand. Wiki explained it eventually.

The first time question took me three weeks to understand. Wiki explained it eventually.

Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.

Yeah, showing the arithmetic is the fastest way for someone to spot the error.

Yes, exactly this, and it is the bit that took me 16 weeks to accept.

regulatory status changed in 13 countries, check yours

Adding to this: sequence is doing more work than the comment implies.

pentadecapeptide is tendon, the supply chain naming is a mess

BPC pentadecapeptide is a naming problem, three things are called this

week two nothing happening — yes, that is normal

Cosigning. The concentration on the vial in marker is load-bearing.

Yeah, 503A and 503B are different regulatory animals.

no "told you so" comments, removed without discussion

stopper coring on the 5th draw because you keep using the same entry point. rotate.

no question too basic, read the wiki first, then ask anyway

Adding to this: week one is doing more work than the comment implies.